a)(semaglutide)b)0.1%(w/w)c)6.4 mg/mld)e)97%f)g)pHHClNaOHpH7-8In some embodiments, the pharmaceutical formulation consists of or essentially consists of: a) semaglutide, optionally b) not more than 0.1% (w/w) phenol, c) more than 6.4 mg /ml of sodium chloride, d) buffer, e) at least 97% water, optionally f) histidine, optionally g) one or more pH adjustment reagents, such as HCl, NaOH or acetate, And the formula optionally has a pH of about 7-8
Effects of novel dual GIP and GLP-1 receptor agonist GLP2 on biomarkers of nonalcoholic steatohepatitis in patients with type 2 diabetes
In contrast to poisoning with phenytoin or carbamazepine, nystagmus, dysarthria and ataxia are rarely noted following VPA overdose
Transform Your Skin Today
For 30 years, I stayed in the exam room, seeing one patient at a time and trying to work within a system I often disagreed with